Identification of an HLA-A1 restricted CTL epitope from Mcl-1

被引：8
作者：
Andersen, MH
Kvistborg, P
Becker, JC
Straten, PT
机构：
[1] Danish Canc Soc, Tumor Immunol Grp, Inst Canc Biol, DK-2100 Copenhagen, Denmark
[2] Univ Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany
来源：
LEUKEMIA | 2005年 / 19卷 / 06期
关键词：
D O I：
10.1038/sj.leu.2403743
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1084 / 1085
页数：3
相关论文
共 5 条
[1]   Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules [J].
Andersen, MH ;
Tan, L ;
Sondergaard, I ;
Zeuthen, J ;
Elliott, T ;
Haurum, JS .
TISSUE ANTIGENS, 2000, 55 (06) :519-531
[2]   The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients [J].
Andersen, MH ;
Becker, JC ;
Straten, PT .
LEUKEMIA, 2005, 19 (03) :484-485
[3]   HLA class I antigen loss, tumor immune escape and immune selection [J].
Campoli, M ;
Chang, CC ;
Ferrone, S .
VACCINE, 2002, 20 :A40-A45
[4]   Part II: Vaccines for haematological malignant disorders [J].
Mocellin, S ;
Semenzato, G ;
Mandruzzato, S ;
Rossi, CR .
LANCET ONCOLOGY, 2004, 5 (12) :727-737
[5]   Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family [J].
Shangary, S ;
Johnson, DE .
LEUKEMIA, 2003, 17 (08) :1470-1481
1